These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 27143511)

  • 1. Targeting dynamics of subclones of GI, liver and pancreatic cancers.
    Ziogas DE; Glantzounis G; Liakakos T; Roukos DH
    Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):773-6. PubMed ID: 27143511
    [No Abstract]   [Full Text] [Related]  

  • 2. Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer.
    Frank TS; Sun X; Zhang Y; Yang J; Fisher WE; Gingras MC; Li M
    Cancer Lett; 2015 Jul; 363(1):1-6. PubMed ID: 25890222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies.
    Matsuoka T; Yashiro M
    World J Gastroenterol; 2016 Jan; 22(2):776-89. PubMed ID: 26811624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing pathology with changing drugs: tumors of the gastrointestinal tract.
    Cervera P; Fléjou JF
    Pathobiology; 2011; 78(2):76-89. PubMed ID: 21677471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-β signaling in liver and gastrointestinal cancers.
    Katz LH; Likhter M; Jogunoori W; Belkin M; Ohshiro K; Mishra L
    Cancer Lett; 2016 Sep; 379(2):166-72. PubMed ID: 27039259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized treatment approach to gastroenteropancreatic neuroendocrine tumors: a medical oncologist's perspective.
    Paul D; Ostwal V; Bose S; Basu S; Gupta S
    Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):985-90. PubMed ID: 27257869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted molecular ablation of cancer stem cells for curing gastrointestinal cancers.
    Kim YS; Lee HJ; Park JM; Han YM; Kangwan N; Oh JY; Lee DY; Hahm KB
    Expert Rev Gastroenterol Hepatol; 2017 Nov; 11(11):1059-1070. PubMed ID: 28707966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Molecular Pathology and Treatment of Periampullary Cancers.
    Chandrasegaram MD; Chen JW; Price TJ; Zalcberg J; Sjoquist K; Merrett ND
    Pancreas; 2016 Jan; 45(1):32-9. PubMed ID: 26348463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of the Hedgehog Pathway in Chemoresistance of Gastrointestinal Cancers.
    Liang Y; Yang L; Xie J
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Old Tyrosine Kinase Inhibitors and Newcomers in Gastrointestinal Cancer Treatment.
    Giordani E; Zoratto F; Strudel M; Papa A; Rossi L; Minozzi M; Caruso D; Zaccarelli E; Verrico M; Tomao S
    Curr Cancer Drug Targets; 2016; 16(2):175-85. PubMed ID: 26278713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Implications of Molecular Subtyping for Pancreatic Cancer.
    Pishvaian MJ; Brody JR
    Oncology (Williston Park); 2017 Mar; 31(3):159-66, 168. PubMed ID: 28299752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updates in Tumor Profiling in Gastrointestinal Cancers.
    Perez K; Safran HP
    R I Med J (2013); 2015 Oct; 98(10):21-4. PubMed ID: 26422541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Speeding towards individualized treatment for pancreatic cancer by taking an alternative road.
    Iovanna J; Dusetti N
    Cancer Lett; 2017 Dec; 410():63-67. PubMed ID: 28947138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aquaporins: Their role in gastrointestinal malignancies.
    Nagaraju GP; Basha R; Rajitha B; Alese OB; Alam A; Pattnaik S; El-Rayes B
    Cancer Lett; 2016 Apr; 373(1):12-18. PubMed ID: 26780474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General paucity of genomic alteration and low tumor mutation burden in refractory and metastatic hepatoblastoma: comprehensive genomic profiling study.
    Lee H; El Jabbour T; Ainechi S; Gay LM; Elvin JA; Vergilio JA; Suh J; Ramkissoon SH; Ali SM; Schrock A; Fabrizio D; Frampton G; Nazeer T; Miller VA; Stephens PJ; Ross JS
    Hum Pathol; 2017 Dec; 70():84-91. PubMed ID: 29079173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. piRNA: A promising biomarker in early detection of gastrointestinal cancer.
    Ameli Mojarad M; Ameli Mojarad M; Shojaee B; Nazemalhosseini-Mojarad E
    Pathol Res Pract; 2022 Feb; 230():153757. PubMed ID: 34998210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic instability in pancreatic adenocarcinoma: a new step towards precision medicine and novel therapeutic approaches.
    Sahin IH; Lowery MA; Stadler ZK; Salo-Mullen E; Iacobuzio-Donahue CA; Kelsen DP; O'Reilly EM
    Expert Rev Gastroenterol Hepatol; 2016 Aug; 10(8):893-905. PubMed ID: 26881472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of liver cancer and personalized therapy.
    Li L; Wang H
    Cancer Lett; 2016 Sep; 379(2):191-7. PubMed ID: 26213370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancer.
    Birnbaum DJ; Bertucci F; Finetti P; Birnbaum D; Mamessier E
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):248-255. PubMed ID: 29499330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Holistic Approaches for Overcoming Therapy Resistance in Pancreatic and Colon Cancers.
    Sarkar FH
    Med Princ Pract; 2016; 25 Suppl 2(Suppl 2):3-10. PubMed ID: 26228733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.